SCHEMBL21592832

SCHEMBL21592832

Cc1cc(-c2cnc3[nH]cc(-c4ccc(OCCCN)cc4)c3c2)cc(C)c1N1CCN(C)CC1

nearest known ligand 0.54

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 4/20 0.54
MAP4K1 Q92918 7/20 0.51
IL2 P60568 3/20 0.50
TNIK Q9UKE5 6/20 0.49
NTRK1 P04629 1/20 0.45
IKBKB O14920 1/20 0.45
CHUK O15111 1/20 0.45
ABL1 P00519 1/20 0.45
INSR P06213 1/20 0.45
CDK2 P24941 1/20 0.45
FLT3 P36888 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21592846 0.97 MAP3K11 (0.53) MAP3K11MAP4K1IL2TNIKNTRK1
SCHEMBL21592561 0.88 MAP4K1 (0.65) MAP3K11MAP4K1IL2TNIK
SCHEMBL28513553 0.86 MAP3K11 (0.49) MAP3K11MAP4K1IL2TNIK
SCHEMBL21592956 0.86 MAP4K1 (0.60) MAP3K11MAP4K1IL2TNIKNTRK1
SCHEMBL28509463 0.85 MAP3K11 (0.48) MAP3K11MAP4K1IL2TNIK
SCHEMBL28906168 0.85 MAP4K1 (0.56) MAP3K11MAP4K1IL2TNIK
SCHEMBL21592695 0.85 MAP4K1 (0.56) MAP3K11MAP4K1IL2TNIK
SCHEMBL21592643 0.83 MAP4K1 (0.66) MAP3K11MAP4K1IL2TNIK
SCHEMBL28507129 0.83 TNIK (0.59) MAP3K11MAP4K1IL2TNIKNTRK1
SCHEMBL28513938 0.83 MAP4K1 (0.56) MAP3K11MAP4K1IL2TNIKIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed
WO-2019238067-A1 PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2019-12-19 WO disclosed